Document Detail

Oral-nasal membranes are not the major route for fetal absorption of amniotic fluid arginine vasopressin.
MedLine Citation:
PMID:  1750454     Owner:  NLM     Status:  MEDLINE    
Intraamniotically injected substances such as arginine vasopressin and digoxin have been found to rapidly appear in the ovine fetal circulation, irrespective of whether the fetal esophagus has been ligated or occluded. To determine if the ovine fetal oral-nasal membrane plays a significant role in this fetal absorption of amniotic substances, we used two groups of chronically catheterized fetal sheep with a surgical glove sewed over the fetal head to prevent access of the head to amniotic fluid. In the first group 22.5 micrograms of arginine vasopressin was injected into the amniotic cavity; in the second group 22.5 micrograms was injected into the glove over the fetal head. We found that, after injection into the amniotic cavity, there were rapid and highly significant increases in amniotic fluid arginine vasopressin concentrations, from 6.1 +/- 1.3 to 51,249 +/- 18,182 pg/ml (mean +/- SE) (p less than 0.00001). Concurrently there was a rapid increase in fetal plasma arginine vasopressin concentrations from 4.5 +/- 1.3 to 93.8 +/- 18.9 pg/ml (p less than 0.00001). The increase was significant within 15 minutes and reached a maximum at 60 minutes after the injection. Fetal arterial pressure increased by 10 +/- 2 mm Hg, whereas heart rate decreased by 30 +/- 5 beats/min (p less than 0.00001). In contrast, after the injection into the glove covering the fetal head, there were no significant changes in any of the measured parameters. This suggests that the ovine fetal oral-nasal membrane is not a significant route of absorption of amniotic fluid arginine vasopressin and that the most likely route of absorption is the vascularized fetal surface of the placenta and vascularized fetal membranes, i.e., the intramembranous pathway.
W M Gilbert; C Y Cheung; R A Brace
Related Documents :
14749654 - How well do the amniotic fluid index and single deepest pocket indices (below the 3rd a...
1856524 - Ultracytochemical study on the permeability of the human amniotic epithelium.
3337164 - Antimicrobial activity of amniotic fluid against chlamydia trachomatis, mycoplasma homi...
746484 - Effect of the duration of dexamethasone treatment on the total phospholipid content of ...
8789624 - Relationship between maternal folate status and foetal hypotrophy in a population with ...
18078364 - Ependymoblastomatous exencephaly: a unique fetal malformation.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  American journal of obstetrics and gynecology     Volume:  165     ISSN:  0002-9378     ISO Abbreviation:  Am. J. Obstet. Gynecol.     Publication Date:  1991 Dec 
Date Detail:
Created Date:  1992-01-23     Completed Date:  1992-01-23     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0370476     Medline TA:  Am J Obstet Gynecol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1614-20     Citation Subset:  AIM; IM    
Department of Reproductive Medicine, University of California, San Diego.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Amniotic Fluid / metabolism*
Arginine Vasopressin / administration & dosage,  blood,  pharmacokinetics*
Blood Pressure / drug effects
Heart Rate, Fetal / drug effects
Mouth Mucosa / metabolism*
Nasal Mucosa / metabolism*
Grant Support
Reg. No./Substance:
113-79-1/Arginine Vasopressin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Elevated fetal plasma lactate produces polyhydramnios in the sheep.
Next Document:  Amniotic fluid volume response to esophageal occlusion in fetal sheep.